Want to see ALLR full AI Analyst Report?
Allarity Therapeutics (ALLR) Income Statement
Allarity Therapeutics Income Statement
Last quarter (Q2 2026), Allarity Therapeutics's total revenue was $0.00. In Q2, Allarity Therapeutics's net income was $-3.40M. See Allarity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 320.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 320.00K | $ 0.00 | $ -37.00K | $ -120.00K | $ -106.00K | |
| $ 12.93M | $ 27.24M | $ 17.13M | $ 34.46M | $ 26.56M | |
| Depreciation and Amortization | $ -13.00K | $ 9.00K | $ 37.00K | $ 60.00K | $ 106.00K |
| $ -11.05M | $ -24.23M | $ -11.28M | $ -17.30M | $ -25.77M | |
| $ -12.61M | $ -27.24M | $ -17.13M | $ -34.46M | $ -26.56M | |
| $ 1.37M | $ 2.35M | $ 5.31M | $ 16.88M | $ 41.00K | |
| $ -11.23M | $ -24.90M | $ -11.82M | $ -17.58M | $ -26.52M | |
| $ -11.23M | $ -24.52M | $ -11.90M | $ -16.06M | $ -26.65M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.78 | $ -15.79 | $ -6031.31 | $ -31799.09 | $ -79074.18 |
| Diluted EPS | $ -0.78 | $ -15.79 | $ -6031.31 | $ -31799.09 | $ -79074.18 |
| Weighted Average Shares Outstanding | 14.38M | 1.61M | 3.32M | 11.34K | 7.57K |
| Weighted Average Shares Outstanding (Diluted) | 14.38M | 1.61M | 3.32M | 11.34K | 7.57K |
Currency in USD
